Megumi Inada-Inoue   Yuichi Ando   Kenji Kawada   Ayako Mitsuma   Masataka Sawaki   Taro Yokoyama   Yu Sunakawa   Hiroo Ishida   Kazuhiro Araki   Keishi Yamashita   Keiko Mizuno   Fumio Nagashima   Akiko Takekura   Kazuo Nagamatsu   Yasutsuna Sasaki   
CANCER CHEMOTHERAPY AND PHARMACOLOGY 73(4) 673-683 2014年4月
Purpose A phase 1 study of pazopanib alone or in combination with lapatinib was conducted to assess the safety, tolerability, and pharmacokinetics of these oral tyrosine kinase inhibitors in Japanese patients with solid tumors.
Methods In part A (...